Hansa Biopharma AB (0RC7.LSE) Q4 2024 Earnings

17OctConfirmed
Q3 2024
Q4 2024
-3.28
-2.71
-2.15
-1.58

Details

Expected EPS
-2.497052594421
Actual EPS
-1.5808923899999998
Surprise EPS
0.92
Surprise Percent
+36.69%

Description

Hansa Biopharma AB (0RC7.LSE) has reported earnings of -1.5808923899999998 per share for Q4 2024.

0 Comments

Share your thoughts